CIBC Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,740,518
| Closed | -$8.56M | – | 1218 |
|
|
2024
Q1 | $8.56M | Buy |
1,740,518
+593,224
| +52% | +$2.92M | 0.03% | 302 |
|
|
2023
Q4 | $10.1M | Buy |
1,147,294
+820,587
| +251% | +$7.21M | 0.04% | 250 |
|
|
2023
Q3 | $3.75M | Buy |
326,707
+93,701
| +40% | +$1.07M | 0.02% | 407 |
|
|
2023
Q2 | $5.9M | Buy |
233,006
+6,338
| +3% | +$160K | 0.02% | 335 |
|
|
2023
Q1 | $7.3M | Sell |
226,668
-185,169
| -45% | -$5.96M | 0.03% | 294 |
|
|
2022
Q4 | $7.6M | Sell |
411,837
-89,332
| -18% | -$1.65M | 0.03% | 277 |
|
|
2022
Q3 | $13.5M | Buy |
+501,169
| New | +$13.5M | 0.06% | 177 |
|
|
2022
Q2 | – | Sell |
-470,819
| Closed | -$9.18M | – | 1500 |
|
|
2022
Q1 | $9.18M | Sell |
470,819
-27,410
| -6% | -$534K | 0.03% | 253 |
|
|
2021
Q4 | $8.13M | Buy |
+498,229
| New | +$8.13M | 0.03% | 292 |
|